A Judicial Panel on Multidistrict Litigation consolidated 13 insulin price-fixing lawsuits and future tag-along cases from states, counties and private entities against three of the largest pharmaceutical companies in the world, who face allegations of over-inflating prices of the insulin they manufacture.